Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The practice guideline 'atopic dermatitis'].

C A F M Bruijnzeel-Koomen1, J H Sillevis Smitt, F S Boukes

  • 1Universitair Medisch Centrum Utrecht, afd. Dermatologie en Allergologie, Utrecht.

Nederlands Tijdschrift Voor Geneeskunde
|August 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Major hazelnut and peanut allergens are potent in basophil activation and cross-react at T-cell level.

Allergy·2018
Same author

Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Effectiveness of alpine climate treatment for children with difficult to treat atopic dermatitis: Results of a pragmatic randomized controlled trial (DAVOS trial).

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Quality of Dutch dermatological guidelines according to AGREE II.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Discrepancy between the clinical and histopathologic diagnosis of soft tissue vascular malformations.

Journal of the American Academy of Dermatology·2017
Same author

Atopic dermatitis characteristics and medication-use patterns in school-age children with AD and asthma symptoms.

Clinical and experimental dermatology·2017
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Employment of safety net enclosures].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The power of a neurodiversity perspective; demedicalizing mental health support].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Topical corticosteroids are recommended for atopic dermatitis treatment. Allergological screening is advised only for acute allergic symptoms, not routine allergen avoidance.

Area of Science:

  • Dermatology
  • Allergology
  • Clinical Medicine

Context:

  • Atopic dermatitis (AD) management guidelines.
  • Lack of evidence for allergen avoidance benefits in AD.
  • Need for evidence-based treatment strategies.

Purpose:

  • To provide recommendations for the management of atopic dermatitis.
  • To clarify the role of allergological screening and allergen avoidance.
  • To outline effective topical and systemic treatment options.

Summary:

  • Allergological screening for atopic dermatitis (AD) should be limited to patients with acute allergic symptoms due to insufficient evidence supporting allergen avoidance benefits.
  • Topical corticosteroids (e.g., class 2-3 daily, then maintenance) are the primary treatment, with topical calcineurin inhibitors as a second-line option.

Related Experiment Videos

  • Systemic cyclosporine is indicated for severe AD. Psychosocial factors and environmental triggers (e.g., wet work, water exposure) are critical considerations.

    • Impact:

    • Optimized treatment protocols for atopic dermatitis.
    • Reduced unnecessary diagnostic procedures like extensive allergological screening.
    • Improved patient quality of life by addressing disease severity and psychosocial aspects.